QSAM Biosciences Announces 1-for-1,000 to 1-for-2,000 Reverse Stock Split Ahead of Merger With Telix >QSAM

Dow JonesApr 16 20:31

QSAM ANNOUNCES REVERSE STOCK SPLIT RATIO AHEAD OF MERGER

GlobeNewswireApr 16 20:30

Radiopharmaceutical Market Expected to Reach ~$14B by 2032

Seeking AlphaFeb 26 01:00

QSAM to Be Acquired by Telix for $33.1M Plus $90M CVR

Seeking AlphaFeb 8 05:23

QSAM Biosciences Signs Definitive Agreement To Be Acquired By Telix Pharmaceuticals >QSAM

Dow JonesFeb 8 05:00

QSAM Biosciences Shares Rise 37% After Merger Term Sheet With Telix Pharma

Dow JonesNov 14, 2023 23:07